Effectiveness and Safety of Intensive Triplet Chemotherapy Plus Bevacizumab, FIr-B/FOx, in Young-Elderly Metastatic Colorectal Cancer Patients

Four-drug regimens, such as FIr-B/FOx schedule, can improve efficacy of first-line treatment of metastatic colorectal cancer (MCRC) patients. The present study specifically evaluates feasibility of FIr-B/FOx first-line intensive regimen in fit young-elderly MCRC patients, representing approximately...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruera, Gemma, Cannita, Katia, Giordano, Aldo Victor, Vicentini, Roberto, Ficorella, Corrado, Ricevuto, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3838846/
https://www.ncbi.nlm.nih.gov/pubmed/24307987
http://dx.doi.org/10.1155/2013/143273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3838846/
https://www.ncbi.nlm.nih.gov/pubmed/24307987
http://dx.doi.org/10.1155/2013/143273

Ejemplares similares